EUDG - ETF AI Analysis

Top Page

WisdomTree Europe Quality Dividend Growth Fund (EUDG)

Rating:66Neutral

Price Target:―

EUDG, the WisdomTree Europe Quality Dividend Growth Fund, earns a solid overall rating thanks to large positions in high-quality companies like Novartis and AstraZeneca, which show strong financial performance, healthy product pipelines, and supportive earnings call sentiment. Other major holdings such as LVMH, Inditex, Nestlé, and BBVA add to the fund’s strength with robust revenue growth, profitability, and generally positive technical trends. The main risks come from some holdings showing signs of rich valuations or overbought technical conditions, and a few names like Deutsche Telekom and Unilever facing bearish momentum, which could introduce short-term volatility.

Positive Factors

Quality European Dividend Focus

The fund targets European companies with a focus on dividend growth and quality, which can appeal to investors seeking a mix of income and stability.

Broad Country and Sector Diversification

Holdings are spread across several major European countries and a wide range of sectors, helping reduce the impact if any single market or industry struggles.

Solid Recent Performance Trend

The ETF has shown steady gains over the past few months, indicating improving momentum in its underlying holdings.

Negative Factors

Relatively High Expense Ratio

The fund’s ongoing fee is on the higher side for an ETF, which can gradually reduce investors’ net returns over time.

Mixed Performance Among Top Holdings

While some major positions have been performing strongly, others have been weak or lagging, which can create uneven results for the fund.

Concentration in Europe with Limited U.S. Exposure

The ETF is heavily focused on European markets with only a small allocation to the U.S., so it may be more sensitive to Europe-specific economic and political risks.

EUDG vs. SPDR S&P 500 ETF (SPY)

AUM70.79M

RegionEurope

Expense Ratio0.58%

Beta0.62

IssuerWisdomTree

Inception DateMay 07, 2014

Dividend Yield2.25%

Asset ClassEquity

Index TrackedWisdomTree Europe Quality Dividend Growth Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume10,827

30 Day Avg. Volume14,869

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

43.57

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering227

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

EUDG Summary

EUDG is an ETF that follows the WisdomTree Europe Quality Dividend Growth Index, focusing on European companies that pay steady dividends and have room to grow. It holds well-known names like Nestlé, Novartis, and Unilever, spread across many sectors such as industrials, health care, and consumer goods. Someone might invest in this fund to get broad, diversified exposure to Europe while aiming for both income from dividends and long-term growth. A key risk is that European stocks can rise and fall with the overall market and regional economic conditions.

How much will it cost me?The WisdomTree Europe Quality Dividend Growth Fund (EUDG) has an expense ratio of 0.58%, meaning you’ll pay $5.80 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, focusing on selecting high-quality European companies with strong dividend growth potential.

What would affect this ETF?Positive drivers for EUDG could include economic growth in Europe, which may boost consumer spending and industrial activity, benefiting sectors like Consumer Defensive and Industrials that have significant weight in the ETF. Additionally, strong performance from top holdings like Novartis and Nestlé, known for their financial stability and global reach, could enhance returns. On the downside, rising interest rates or economic slowdowns in Europe could negatively impact dividend-paying companies and consumer-focused sectors, while regulatory changes or geopolitical tensions might create uncertainty for businesses in the region.

EUDG Top 10 Holdings

EUDG is leaning heavily on Europe’s healthcare and consumer giants to do the heavy lifting. Swiss pharma leaders Novartis and Roche are rising steadily, helping set the pace, while AstraZeneca adds more fuel to the health-care engine. On the consumer side, Nestlé and Unilever are quietly climbing, offering a stabilizing backbone, and fashion powerhouse Inditex has been another bright spot. The main drag comes from luxury icon LVMH, which has been losing steam lately. Overall, the fund is solidly Europe-focused, with strength clustered in defensive, dividend-friendly names.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOVN	Novartis AG	5.21%	$3.64M	CHF229.98B	24.67%	80 Outperform
NESN	Nestlé SA	5.06%	$3.54M	CHF202.39B	2.00%	71 Outperform
ROG	Roche Holding AG	4.47%	$3.13M	CHF254.35B	25.81%	73 Outperform
MC	LVMH Moet Hennessy Louis Vuitton	3.58%	$2.51M	€246.06B	-18.25%	78 Outperform
ITX	Inditex	3.39%	$2.37M	€163.65B	17.41%	78 Outperform
BP	BP p.l.c.	3.35%	$2.34M	£81.34B	26.65%	71 Outperform
DTE	Deutsche Telekom	2.97%	$2.08M	€160.41B	-2.40%	67 Neutral
BBVA	Banco Bilbao Vizcaya Argentaria	2.91%	$2.04M	€103.56B	37.79%	76 Outperform
AZN	AstraZeneca	2.80%	$1.96M	$297.58B	20.89%	80 Outperform
ULVR	Unilever	2.51%	$1.76M	£105.49B	―	72 Outperform

EUDG Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

38.87

Negative

100DMA

37.48

Negative

200DMA

36.01

Positive

Market Momentum

MACD

-0.56

Positive

RSI

26.21

Positive

STOCH

12.85

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EUDG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 38.94, equal to the 50-day MA of 38.87, and equal to the 200-day MA of 36.01, indicating a neutral trend. The MACD of -0.56 indicates Positive momentum. The RSI at 26.21 is Positive, neither overbought nor oversold. The STOCH value of 12.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EUDG.

EUDG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
EUDG	―	―	$70.79M	0.58%	66 Neutral
VGK	―	―	$30.72B	0.06%	61 Neutral
DBEZ	―	―	$70.39M	0.45%	60 Neutral
FLEU	―	―	$66.81M	0.09%	63 Neutral
PTEU	―	―	$33.13M	0.65%	62 Neutral
XEML	―	―	$5.03M	0.35%	69 Neutral

Performance Comparison

EUDG

WisdomTree Europe Quality Dividend Growth Fund

36.56

3.38

10.19%

VGK

Vanguard FTSE Europe ETF

―

DBEZ

Xtrackers MSCI Eurozone Hedged Equity ETF

―

FLEU

Franklin FTSE Eurozone ETF

―

PTEU

Pacer Trendpilot European Index ETF

―

XEML

Xtrackers Europe Market Leaders ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents